A
35%; 52%
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
In a study by MacDougall et al presented at the 2022 ASCO Quality Care Symposium (Abstract 147), researchers looked at changes in DLBCL survival rates over a nearly 30-year period and explored potential differential survival patterns by patients’ race and age.